Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

413 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer.
Terazaki Y, Yoshiyama K, Matsueda S, Watanabe N, Kawahara A, Naito Y, Suekane S, Komatsu N, Ioji T, Yamada A, Mine T, Terasaki M, Itoh K, Takamori S, Sasada T. Terazaki Y, et al. Among authors: terasaki m. Cancer Sci. 2012 Apr;103(4):638-44. doi: 10.1111/j.1349-7006.2012.02202.x. Epub 2012 Feb 13. Cancer Sci. 2012. PMID: 22321067 Free PMC article. Clinical Trial.
Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients.
Suekane S, Yutani S, Yamada A, Sasada T, Matsueda S, Takamori S, Toh U, Kawano K, Yoshiyama K, Sakamoto S, Sugawara S, Komatsu N, Yamada T, Naito M, Terasaki M, Mine T, Itoh K, Shichijo S, Noguchi M. Suekane S, et al. Among authors: terasaki m. Int J Oncol. 2020 Jun;56(6):1479-1489. doi: 10.3892/ijo.2020.5019. Epub 2020 Mar 19. Int J Oncol. 2020. PMID: 32236612 Free PMC article.
[Personalized peptide vaccination].
Itoh K, Takahashi R, Yoshitomi M, Terasaki M, Noguchi M. Itoh K, et al. Among authors: terasaki m. Nihon Rinsho. 2012 Dec;70(12):2118-23. Nihon Rinsho. 2012. PMID: 23259383 Review. Japanese.
A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma.
Narita Y, Arakawa Y, Yamasaki F, Nishikawa R, Aoki T, Kanamori M, Nagane M, Kumabe T, Hirose Y, Ichikawa T, Kobayashi H, Fujimaki T, Goto H, Takeshima H, Ueba T, Abe H, Tamiya T, Sonoda Y, Natsume A, Kakuma T, Sugita Y, Komatsu N, Yamada A, Sasada T, Matsueda S, Shichijo S, Itoh K, Terasaki M. Narita Y, et al. Among authors: terasaki m. Neuro Oncol. 2019 Feb 19;21(3):348-359. doi: 10.1093/neuonc/noy200. Neuro Oncol. 2019. PMID: 30500939 Free PMC article. Clinical Trial.
[Peptide vaccination in glioblastoma].
Terasaki M, Morioka M. Terasaki M, et al. Gan To Kagaku Ryoho. 2014 Jun;41(6):725-9. Gan To Kagaku Ryoho. 2014. PMID: 25167577 Japanese. No abstract available.
JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.
Wakabayashi T, Natsume A, Mizusawa J, Katayama H, Fukuda H, Sumi M, Nishikawa R, Narita Y, Muragaki Y, Maruyama T, Ito T, Beppu T, Nakamura H, Kayama T, Sato S, Nagane M, Mishima K, Nakasu Y, Kurisu K, Yamasaki F, Sugiyama K, Onishi T, Iwadate Y, Terasaki M, Kobayashi H, Matsumura A, Ishikawa E, Sasaki H, Mukasa A, Matsuo T, Hirano H, Kumabe T, Shinoura N, Hashimoto N, Aoki T, Asai A, Abe T, Yoshino A, Arakawa Y, Asano K, Yoshimoto K, Shibui S; Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG). Wakabayashi T, et al. Among authors: terasaki m. J Neurooncol. 2018 Jul;138(3):627-636. doi: 10.1007/s11060-018-2831-7. Epub 2018 Mar 20. J Neurooncol. 2018. PMID: 29557060 Free PMC article. Clinical Trial.
413 results